AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial

Malden, MA (PRWEB) August 08, 2022 -- AxioMed LLC shows its determination to press forward on its FDA submission of Module III documents needed to get FDA

Related Keywords

Australia ,United States ,Erik Spayde ,Kingsleyr Chin ,Aditya Humad ,Kicventures Group ,Vito Lore ,Chief Financial Officer ,Cleveland Clinic ,Art Steffee ,Axiomed Viscoelastic Disc Technologies ,Press Release ,